Induced fit in liver X receptor beta: A molecular dynamics-based investigation

Proteins: Structure, Function and Genetics

Volumn 72, Issue 3, 2008, Pages 873-882

  Beautrait, Alexandre ^a   Karaboga, Arnaud S ^b   Souchet, Michel ^b   Maigret, Bernard ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Laboratoires Fournier SA   (France)

Author keywords

Induced fit; Liver X receptor; Molecular dynamics; Protein flexibility; Structure based drug design

Indexed keywords

LIGAND; LIVER X RECEPTOR BETA;

ARTICLE; COMPLEX FORMATION; CONFORMATION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; LIGAND BINDING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; RELIABILITY;

COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; DNA-BINDING PROTEINS; LIGANDS; MODELS, MOLECULAR; ORPHAN NUCLEAR RECEPTORS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 47349108518     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21977     Document Type: Article

References (42)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
2. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000;16:459-481.
3. Zhang Y, Mangelsdorf DJ. LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing. Mol Interv 2002;2:78-87.
4. Repa JJ, Mangelsdorf DJ. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol 1999;10:557-563.
5. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-731.
6. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137-3140.
7. Williams S, Bledsoe RK, Collins JL, Boggs S, Lambert MH, Miller AB, Moore J, McKee DD, Moore L, Nichols J, Parks D, Watson M, Wisely B, Willson TM. X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch. J Biol Chem 2003;278:27138-27143.
8. Farnegardh M, Bonn T, Sun S, Ljunggren J, Ahola H, Wilhelmsson A, Gustafsson JA, Carlquist M. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J Biol Chem 2003;278:38821-38828.
9. Hoerer S, Schmid A, Heckel A, Budzinski RM, Nar H. Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist. J Mol Biol 2003;334:853-861.
10. Svensson S, Ostberg T, Jacobsson M, Norstrom C, Stefansson K, Hallen D, Johansson IC, Zachrisson K, Ogg D, Jendeberg L. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J 2003;22:4625-4633.
11. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Mol Biol 1996;3:87-94.
12. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure or the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 1995;375:377-382.
13. Egea P, Klaholz B, Moras D. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett 2000;476:62-67.
14. Castrillo A, Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 2004;20:455-480.
15. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006;116:607-614.
16. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A, Saez E. The nuclear receptor LXR is a glucose sensor. Nature 2007;445:219-223.
17. Terasaka N, Hiroshima A, Koieyama T, Ubukata N, Morikawa Y, Nakai D, Inaba T. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett 2003;536:6-11.
18. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 2002;99:7604-7609.
19. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B. Role of LXRs in control of lipogenesis. Genes Dev 2000;14:2831-2838.
20. Koshland D, Jr. The key-lock theory and the induced fit theory. Angew Chem Int Ed Engl 1994;33:2375-2378.
21. Gunther J, Bergner A, Hendlich M, Klebe G. Utilising structural knowledge in drug design strategies: applications using Relibase. J Mol Biol 2003;326:621-636.
22. Hendlich M, Bergner A, Gunther J, Klebe G. Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions. J Mol Biol 2003;326:607-620.
23. Kleywegt GJ, Jones TA. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr Sect D Biol Crystallogr 1994;50 (Part 2):178-185.
24. Fiser A, Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 2003;374:461-491.
25. Phillips J, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel R, Kale L, Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem 2005;26:1781-1802.
26. MacKerell AD, Jr., Bashford D, Bellott M, Dunbrack RL, Jr., Evanseek JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, III, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiorkiewicz-Kuczera J, Yin D, Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem 1998;102:3586-3616.
27. Momany F, Rone R. Validation of the general purpose QUANTA 3.2/CHARMm force field. J Comput Chem 1992;13:888-900.
28. Humphreys D, Freisner R, Berne B. A multiple-time-step molecular dynamics algorithm for macromolecules. J Phys Chem 1994;98:6885-6892.
29. Kräutler V, van Gunsteren WF, Hünerberger PH. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem 2001;22:501-508.
30. Darden T, York D, Pedersen L. Particle mesh Ewald: An N.log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089-10092.
31. Humphrey W, Dalke A, Schulten K. VMD-visual molecular dynamics. J Mol Graph 1996;14:33-38.
32. Hunter C, Lawson K, Perkins J, Urch C. Aromatic interactions. J Chem Soc Perkin Trans 2 2001:651-669.
33. McGaughey G, Gagne M, Rappe A. π-Stacking interactions. Alive and well in proteins. J Biol Chem 1998;273:15458-15463.
34. Senapati S, Bui J, McCammon J. Induced fit in mouse acetylcholinesterase upon binding a femtomolar inhibitor: a molecular dynamics study. J Med Chem 2005;48:8155-8162.
35. Sotriffer C, Krämer O, Klebe G. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations. Proteins 2004;56:52-66.
36. Verli H, Guimaraes J. Insights into the induced fit mechanism in antithrombin-heparin interaction using molecular dynamics simulations. J Mol Graph Model 2005;24:203-212.
37. Macek P, Novak P, Krizova H, Zidek L, Sklenar V. Molecular dynamics study of major urinary protein-pheromone interactions: a structural model for ligand-induced flexibility increase. FEBS Lett 2006;580:682-684.
38. Singh J, Thornton J.Atlas of protein side-chain interactions, Vols. 1 and 2. Oxford, UK: IRL Press; 1992.
39. Collins J, Fivush A, Watson M, Galardi C, Lewis M, Moore L, Parks D, Wilson J, Tippin T, Binz J, Plunket K, Morgan D, Beaudet E, Whitney K, Kliewer S, Willson T. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002;45:1963-1966.
40. Alonso H, Bliznyuk A, Gready J. Combining docking and molecular dynamic simulations in drug design. Med Res Rev 2006;26:531-568.
41. Sivanesan D, Rajnarayanan R, Doherty J, Pattabiraman N. In-silico screening using flexible ligand binding pockets: a molecular dynamics-based approach. J Comput Aided Mol Des 2005;19:213-228.
42. Wong C, Kua J, Zhang Y, Straatsma T, McCammon J. Molecular docking of balanol to dynamics snapshots of protein kinase A. Proteins 2005;61:850-858.